| Financial Year |
March 31 2023 |
| Monetary Funds |
486,497,194.59 |
| Held-for-trading Financial Assets |
76,456,756.71 |
| Notes Receivable |
760,000.00 |
| Accounts Receivable |
443,482,867.13 |
| Advances to Suppliers |
19,092,978.53 |
| Other Receivables |
16,998,971.58 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
800,000.00 |
| Inventories |
333,850,110.29 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
134,850,652.90 |
| Total Current Assets |
1,832,012,147.48 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
870,928.55 |
| Investment Properties |
23,917,421.39 |
| Fixed Assetes |
134,847,861.84 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
28,916,554.34 |
| R&D expenses |
-- |
| Goodwill |
19,839,560.45 |
| Long-Term Deferred and Prepaid Expenses |
2,390,258.83 |
| Deferred Income Tax Assets |
71,940,254.71 |
| Other Non-Current Assets |
3,498,296.12 |
| Sub-Total of Non-Current Assets |
323,089,646.90 |
| Total Assets |
2,155,101,794.38 |
| Short-Term Loans |
120,065,002.52 |
| Trading Financial liabilities |
-- |
| Notes Payable |
35,808,364.40 |
| Accounts Payable |
462,919,392.06 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
21,980,339.78 |
| Taxes Payable |
29,486,017.94 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
28,152,744.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,307,959.58 |
| Other Current Liabilities |
3,094,932.23 |
| Sub-Total of Current Liabilities |
749,394,829.18 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
7,970,310.44 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
19,650,318.83 |
| Total Liabilities |
769,045,148.01 |
| Paid-In Capital(Or Share Stock) |
651,544,156.00 |
| Capital Surplus |
364,299,205.03 |
| Surplus Reserve |
74,134,085.99 |
| LESS:Treasury Stock |
39,947,195.98 |
| Undistributed Profits |
332,653,671.00 |
| Minority Stockholder's Interest |
3,757,467.68 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,382,299,178.69 |
| Owner's Equity（Stockholder's Equity） |
1,386,056,646.37 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,155,101,794.38 |
